Cargando…
Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208877/ https://www.ncbi.nlm.nih.gov/pubmed/35747842 http://dx.doi.org/10.1097/HS9.0000000000000731 |
| _version_ | 1784729807686205440 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9208877 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92088772022-06-22 Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies Hemasphere Correction Lippincott Williams & Wilkins 2022-05-12 /pmc/articles/PMC9208877/ /pubmed/35747842 http://dx.doi.org/10.1097/HS9.0000000000000731 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Correction Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title | Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_full | Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_fullStr | Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_full_unstemmed | Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_short | Correction Notice: Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_sort | correction notice: serologic responses to covid-19 vaccines in hematological patients are predominantly impaired in lymphoid but not in myeloid malignancies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208877/ https://www.ncbi.nlm.nih.gov/pubmed/35747842 http://dx.doi.org/10.1097/HS9.0000000000000731 |